Skip to main content
Premium Trial:

Request an Annual Quote

IntegenX Names First Partner for RapidHit 200 Early Access Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IntegenX today announced the launch of its Early Access Program for the RapidHit 200 Human Identification System and the signing of Key Forensic Sciences as the first international partner of the program.

The new program provides IntegenX's partners with advanced product access and training, and partners will receive pre-production prototypes of the RapidHit 200 instrument, disposable reagent cartridges, and application priority in the US and abroad, the Pleasanton, Calif.-based company said.

As the first partner in the Early Access Program, Key Forensic Sciences will be able to optimize and use the RapidHit 200 instrument for commercial forensic services in the UK, where it is based. Objectives of the partnership include validation of the system and introduction of fast human ID services to police forces in the UK and Wales.

RapidHit 200 automates and accelerates production of standardized DNA profiles from mouth swabs and other human tissue samples.

Terms of the deal were not disclosed.